Maria Hjortsmark

Cellomics, Inc. provides imaging technology products and services. It is a provider of technologies and products for the advancement of cell science research, including complete systems for high-content imaging of cells, tissues and whole organisms. The firm's platform includes automated imaging instruments, image analysis software, data management and bioinformatics software, coupled with reagents, cell-culture media, sera and specialty media formulations, along with laboratory automation and services. The company's offering is aimed at providing life science researchers with a quantitative, automated approach to understanding the biology of cells, including stem cells and cell systems, supporting all aspects of the drug discovery process as well as academic and systems biology research. Cellomics was founded on October 1996 and is headquartered in Pittsburgh, PA.

UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany.

PerkinElmer Life & Analytical Sciences, Inc. provides medical and biotechnology research instruments. The firm's services include drug discovery, genetic screening, environmental assessment, forensics, life science research, chemical analysis processes, scientific research, materials characterization, and clinical applications for the biopharmaceutical companies. The company is headquartered in Waltham, MA.

Accuri Cytometers, Inc. develops and manufactures personal flow cytometers for researchers. It operates as a life sciences company which develops and markets high performance cell analysis systems designed to bring the power of flow cytometry into life science and biomedical laboratories. The firm offers C6 Flow Cytometer, a bench-top cell and bead analysis system used in various applications, such as immunophenotyping, bacteria analysis, cell cycle analysis, proliferation assays, apoptosis, DNA analysis, target multiplexing, gene expression, lineage analysis, viability, absolute cell counts, intracellular cytokines, membrane potential, yeast and algae analysis, and phagocytosis. The company was founded by Jennifer A. Baird and Collin A. Rich in 2004 and is headquartered in Ann Arbor, MI.

Odlander Fredrikson & Co. AB provides financial support services. The company was founded in 1996 and is headquartered in Stockholm, Sweden.

Part of Sanofi, Sanofi Winthrop is a French company that specializes in medicinal chemicals and botanical products. The company is based in Paris, France.

Holzworth Holdings, Inc. conducts health research and provides technical, professional, and consulting services. The company was founded on December 19, 1996 and is headquartered in Durham, NC.

Part of Pfizer Inc., Pharmacia AB /Hillerod Unit/ is a pharmaceutical company based in Hillerod, Sweden. Pharmacia AB /Hillerod Unit was acquired by Pharmacia AB /Hillerod UnitManagement/ on January 10, 2001.

Sigma Entity One Ltd. provides solid-form research services to the pharmaceutical and biotech markets. The company was founded by David Tapolczay and Daniel Rowland Cowell on July 16, 2003 and is headquartered in Gillingham, the United Kingdom.

Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden.

duPont Publishing, Inc. publishes magazines that focuses on luxury sports car, elegant homes, motor yachts, and gadgets. The company was founded in 1984 and is headquartered in Clearwater, FL.

Masimo Sweden AB develops and markets ultra-small gas monitoring probes. It sells mobile multigas analyzers that enable to measure respiratory gases in any clinical application. The firms products include IRMA Mainstream Analyzers, ISA Sidestream Analyzers, Nomoline Sampling Lines, EMMA Capnometers, and EMMA Carnograph. The company was founded by Anders Eckerbom and Robert Zyzanski in 1989 and is headquartered in Danderyd, Sweden.

The Michigan Biosciences Industry Association is an official bio-industry association that serves various sectors such as pharmaceutical, medical device, ag-bio, r&d, health IT, and life science logistics. The company is based in Ann Arbor, MI. The association provides cost-savings on business essentials, industry connections and networking, talent support, advocacy, and more. The CEO of the company is Stephen Rapundalo.

Sjätte AP-fonden (AP6) is a private equity division of Sjätte AP-fonden founded in 1996. the firm is headquartered in Gothenburg, Stockholm.

Medical Vision AB provides medical devices used during endoscopic surgeries. It develops, manufactures and markets medical devices within the field of Arthroscopic surgery. The firm's core product is called Double Pump, and is used to flush fluids through the joint with a controlled pressure and flow to increase visualization during the procedure. The company was founded by Anders Gunnar Möllstam in 2003 and is headquartered in Nacka, Sweden.

Protein Technologies, Inc. engages in the design, manufacture and supply of solid phase synthesizers. The company was founded in 1985 and is headquartered in Tucson, AZ.

Tekniikan Akatemia -säätiö sr, also known as Technology Academy Finland (TAF), is based in Helsinki, Finland. The CEOs of the Finnish company are Mikko Salaspuro and Ainomaija Susanna Haarla. TAF awards the €1 million Millennium Technology Prize and organizes associated events and initiatives. The private company provides an international meeting ground for corporate life, academia, and policymakers, and promotes Finland's position in the community. The Millennium Technology Prize is the world's most prestigious award for breakthrough innovations that improve the quality of people's lives.

Bankinvest Biomedical Venture provides investment services. The company was founded in 1998 and is headquartered in Copenhagen, Denmark.

Arthur D. Little Benelux NV SA is a global management consultancy specializing in strategy and operations management, serving major corporations and organizations worldwide. They are recognized as leaders in linking strategy, innovation and technology to solve their clients' most complex business issues, delivering sustainable solutions. They are distinguished from others by their deep industry insight and technology expertise. The company was founded in 1967 and is headquartered in Brussels, Belgium.

Aniona ApS is a private company based in Ballerup, Denmark. Jørgen Drejer has been the CEOs since incorporation. The Danish company was founded by Thomas Feldthus, Anker Gunvald Lundemose, Claus Tycho Bræstrup, Jørgen Drejer.

Gyros Protein Technologies AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. It provides sample preparation, synthesis and bioanalytical tools for biotherapeutics discovery, development and bioprocessing. The company was founded in March 2016 and is headquartered in Uppsala, Sweden.

Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders.